Last reviewed · How we verify

NCT06079580

Patients With Lumbar Spinal Stenosis With Balance Disorder

Completed Last updated 25 April 2024
What this trial tests

trial in Lumbar Spinal Stenosis in 64 participants. Completed in 15 January 2024.

Timeline
1 September 2023
Primary endpoint
15 December 2023
15 January 2024

Quick facts

Lead sponsorKarabuk University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment64
Start date1 September 2023
Primary completion15 December 2023
Estimated completion15 January 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Karabuk University

Who can join

Adults 45 to 80, any sex, with Lumbar Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is seen that patients with Lumbar Spinal Stenosis often experience balance problems. Although the relationship between muscle thickness and balance has been explained, there are insufficient studies investigating the relationship between balance problems and muscle thickness in patients with LSS. In addition, no study has been found comparing the difference in muscle thickness and cross-sectional area in LSS patients with poor and normal balance. In addition, in LSS, pain, disability and fear of falling in balance disorders are nor clear. The aim of our study is to examine the relationship between balance and biopsychosocial factors that can affect it.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lumbar Spinal Stenosis

Currently open trials in the same condition.

Other Karabuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing